Compare the Quality of Life in Type 2 Diabetic Patients with Healthy Individuals (Application of WHOQOL-BREF)

Abstract

Background: Diabetes is a chronic disease that its prevalence will double in the world by 2030. According to the report of world health organization (WHO) in 2014, diabetes is the fourth main disease contributing to premature death among Iranians. Objectives: According to the third national program of care system for risk factors of non-communicable diseases, the prevalence of diabetes is reported to be more than 8 percent. Given the high prevalence of diabetes and its importance, the aim of this study was compare the quality of life in patients with type II diabetes and healthy people in Kerman. Methods: This study was a cross-sectional. Two hundred diabetic patient and 200 healthy people participated in this study. The WHOQOL-BREF was used to collect data. Results: This study showed that score of quality of life in all dimension in diabetic patients were fewer than healthy people impressively (P < 0.05). The score of quality of life in physical dimension was higher in men than women (P = 0.035) and it was also higher in people graduated in diploma than other levels of education (P = 0.047). Conclusions: To recapitulate, since chronic diabetes disease is not fatal, the patients will not be recovered and they practically have the disease and its complications over their entire life, it is recommended to address the quality of life among these patients' especially physical and psychological domains.

Health-related quality of life and associated factors among patients with diabetes mellitus at the University of Gondar referral hospital

“…A possible explanation might be differences in measurement tools. A study in Iran with WHOQOL-BREF [23] shows the four domains of HRQOL are higher than those of the current study. A possible explanation might be differences in economic status, satisfaction with the infrastructure and health care service and clinical characteristics of patients.…”

“…All adult diabetic patients on follow-up for at least 6 months were included, whereas individuals with gestational diabetes and patients who were unable to communicate were excluded. The sample size was determined using a power approach (double population formula) from a previous study [23] by considering type I error of 0.05, type II error of 0.10, confidence interval 95%, standard deviation (SD) one 17.22, SD two 13.79, mean difference 5.2 and non-response 10%. Therefore, the final sample size of the study was 416.…”

Continuity of Care and the Quality of Life among Patients with Type 2 Diabetes Mellitus: A Cross-Sectional Study in Taiwan

“…The overall mean score of QoL for patients with T2DM was 53.42/80, with an indicator score of 66.7. This QoL score was higher than that reported in other countries [ 6 , 37 ], which may be attributed to differences in patients, ethnicity, and region [ 7 , 12 ].…”

“…The study sample size was estimated using G*Power 3.0.10 (Heinrich-Heine-Universität Düsseldorf, Dusseldorf, Germany) [ 29 ] with an alpha value of 0.05, power of 0.8, and effect size set to 0.30. Referring to the effect size of 0.30 suggested by Tavakkoli and Dehghan [ 6 ], a sample size of 104 patients was found to be sufficient. In terms of the loss rate, 10% for refusal to participate and 10% for withdrawal from the study were estimated [ 17 ].…”

“…Recently, diabetes care has moved from focusing only on mortality or morbidity [ 3 ] to placing more emphasis on quality of life (QoL) [ 4 ]. Despite several studies on the disease [ 4 , 5 , 6 ], there is little research on the correlation between continuity of care (CoC) and QoL among patients with diabetes, and there is a need for in-depth understanding and discussions. Diabetes can cause pathological conditions in multiple organs, including cardiovascular disease, kidney failure, retinopathy, neuropathy, and gastrointestinal lesions [ 2 ]; the most common psychosocial outcome is depression [ 7 ].…”